This article is a correction to:
High Complement Factor H-Related (FHR)-3 Levels Are Associated With the Atypical Hemolytic-Uremic Syndrome-Risk Allele CFHR3*B
Richard B. Pouw1,2
Irene Gómez Delgado3
Alberto López Lera4
Santiago Rodríguez de Córdoba5
Diana Wouters1Taco W. Kuijpers2,6
Pilar Sánchez-Corral3*- 1Department of Immunopathology, Sanquin Research and Landsteiner Laboratory of the Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands
- 2Department of Pediatric Hematology, Immunology and Infectious Diseases, Emma Children's Hospital, Academic Medical Center, Amsterdam, Netherlands
- 3Complement Research Group, Hospital La Paz Institute for Health Research (IdiPAZ), La Paz University Hospital, Center for Biomedical Network Research on Rare Diseases (CIBERER), Madrid, Spain
- 4Immunology Unit, Hospital La Paz Institute for Health Research (IdiPAZ), La Paz University Hospital, Center for Biomedical Network Research on Rare Diseases (CIBERER), Madrid, Spain
- 5Biological Research Center (CIB)-CSIC, Center for Biomedical Network Research on Rare Diseases (CIBERER), Madrid, Spain
- 6Department of Blood Cell Research, Sanquin Research and Landsteiner Laboratory of the Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands
A Corrigendum on
High Complement Factor H-Related (FHR)-3 Levels Are Associated With the Atypical Hemolytic-Uremic Syndrome-Risk Allele CFHR3*B
by Pouw, R. B., Gómez Delgado, I., López Lera, A., Rodríguez de Córdoba, S., Wouters, D., Kuijpers, T. W., et al. (2018). Front. Immunol. 9:848. doi: 10.3389/fimmu.2018.00848
There is an error in the Acknowledgments statement. The correct name for the funder “Spanish Ministerio de Economía y Competitividad” is “Spanish Instituto de Salud Carlos III.”
A correction has been made to the Acknowledgments section:
“We appreciate the technical assistance of Lorena Risueño, César Vélez, and Álex Otero in the management of biological samples of patients and controls. We thank Rosario Madero (IdiPAZ Biostatistics) for statistical help, and Vega Mauleón and Hoi Tong (IdiPAZ UCICEC) for blood sampling of the healthy Spanish volunteers. This study was funded by the Spanish Instituto de Salud Carlos III and the European Program FEDER (grants PI12/00597 and PI16/00723 to PS-C, and grant SAF2015-66287-R to SR), and by the Complement II-CM network (B2017/BMD-3673). RP and TK received funding from the European Union's seventh Framework program under EC-GA no. 279185 (EUCLIDS; www.euclids-project.eu). AL is supported by the Spanish Center for Biomedical Network Research on Rare Diseases (CIBERER).”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Keywords: complement, factor H, factor H-related protein 3, CFHR3 gene, atypical hemolytic-uremic syndrome
Citation: Pouw RB, Gómez Delgado I, López Lera A, Rodríguez de Córdoba S, Wouters D, Kuijpers TW and Sánchez-Corral P (2020) Corrigendum: High Complement Factor H-Related (FHR)-3 Levels Are Associated With the Atypical Hemolytic-Uremic Syndrome-Risk Allele CFHR3*B. Front. Immunol. 10:3073. doi: 10.3389/fimmu.2019.03073
Received: 12 December 2019; Accepted: 16 December 2019;
Published: 24 January 2020.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2020 Pouw, Gómez Delgado, López Lera, Rodríguez de Córdoba, Wouters, Kuijpers and Sánchez-Corral. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Pilar Sánchez-Corral, pilar.sanchez-corral@idipaz.es